Literature DB >> 22691114

The importance of genetic variants in TNFα for periodontal disease in a cohort of coronary patients.

Susanne Schulz1, Axel Schlitt, Andrea Lutze, Sandra Lischewski, Tim Seifert, Tanya Dudakliewa, Robert Gawe, Karl Werdan, Britt Hofmann, Christiane Gläser, Hans-Günter Schaller, Stefan Reichert.   

Abstract

AIM: The aim of this analysis was to evaluate the importance of genetic variants of TNFα for the severity of periodontal disease and periodontal risk factors with respect to periodontal risk factors in a cohort of coronary patients.
SUBJECTS: A total of 942 consecutive patients with angiographic proven coronary heart disease were prospectively included in the study entitled "Periodontitis and Its Microbiological Agents as Prognostic Factors in Patients With Coronary Heart Disease" (ClinicalTrials.gov identifier:NCT01045070).
METHODS: After including of patients, an extensive periodontal examination also involving PCR-sampling for 11 periodontal bacteria was performed. In this subanalysis, single nucleotide polymorphisms (SNPs) c.-308G>A, c.-238G>A and haplotypes for TNFα were analysed by CTS-PCR-SSP Tray kit (Heidelberg, Germany).
RESULTS: The AG+AA genotype of SNP c.-238G>A of TNFα gene was associated with the amount of clinical attachment loss in patients with coronary heart disease in multivariate regression analysis. Moreover, Prevotella intermedia occurred more frequently in carriers who were positive for the AG+AA genotype and A-allele of SNP c.-308G>A in bivariate and multivariate analyses. Furthermore, only in bivariate analyses significant associations of genetic variants of TNFα with intensified bleeding on probing and with higher plasma level of interleukin 6 could be shown.
CONCLUSIONS: Genetic variants of TNFα gene, namely c.-308G>A and c.-238G>A, are associated with periodontal conditions in patients with coronary heart disease.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22691114     DOI: 10.1111/j.1600-051X.2012.01909.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  7 in total

1.  Rehabilitation in Patients With Coronary Heart Disease: Participation and Its Effect on Prognosis.

Authors:  Axel Schlitt; Patricia Wischmann; Andreas Wienke; Florian Hoepfner; Frank Noack; Rolf-Edgar Silber; Karl Werdan
Journal:  Dtsch Arztebl Int       Date:  2015-08-03       Impact factor: 5.594

2.  Polymorphisms in the interleukin-10 gene and chronic periodontitis in patients with atherosclerotic and aortic aneurysmal vascular diseases.

Authors:  Zahra Armingohar; Jørgen J Jørgensen; Anne K Kristoffersen; Karl Schenck; Zlatko Dembic
Journal:  J Oral Microbiol       Date:  2015-02-19       Impact factor: 5.474

Review 3.  The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS).

Authors:  Bernhard Rauch; Constantinos H Davos; Patrick Doherty; Daniel Saure; Maria-Inti Metzendorf; Annett Salzwedel; Heinz Völler; Katrin Jensen; Jean-Paul Schmid
Journal:  Eur J Prev Cardiol       Date:  2016-10-25       Impact factor: 7.804

Review 4.  Periodontal inflammation: Integrating genes and dysbiosis.

Authors:  Shaoping Zhang; Ning Yu; Roger M Arce
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

5.  Detection of association between periodontitis and polymorphisms of IL-1β + 3954 and TNF-α -863 in the Korean population after controlling for confounding risk factors.

Authors:  Hyun-Joo Kim; Eun-Hye Kim; Ae Kyung Park; Yerang Shin; Jihoon Kang; Jaesung Lim; Jong Bhak; Ju-Youn Lee; Byung Chul Kim; Ji-Young Joo
Journal:  J Periodontal Res       Date:  2020-07-03       Impact factor: 4.419

Review 6.  Periodontal Infectogenomics.

Authors:  Gurjeet Kaur; Vishakha Grover; Nandini Bhaskar; Rose Kanwaljeet Kaur; Ashish Jain
Journal:  Inflamm Regen       Date:  2018-05-07

7.  Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-II).

Authors:  Annett Salzwedel; Katrin Jensen; Bernhard Rauch; Patrick Doherty; Maria-Inti Metzendorf; Matthes Hackbusch; Heinz Völler; Jean-Paul Schmid; Constantinos H Davos
Journal:  Eur J Prev Cardiol       Date:  2020-02-23       Impact factor: 7.804

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.